Canada Spends Logo

Explore our Budget 2026 analysis

Grant: III: Pandemic Preparedness Strategic Research Initiative

University of British Columbia

$100,000.00

Characterization of the response of human B lymphocytes to infection with the novel H1N1 pandemic influenza

FY 2009-10

Summary
The H1N1 influenza pandemic arose when a new strain of influenza virus emerged and spread rapidly because most humans had no immunity to it. Immunity to a particular variety of influenza virus is due to the formation of antibodies (proteins that circulate in the blood) that specifically bind to that type of influenza virus and neutralize its ability to infect us. We developed a technique that, this summer, enabled us to generate potentially unlimited amounts of human antibodies that neutralize swine flu. We did this by making faithful copies of antibodies from samples of blood from patients who had recovered from swine flu. Surprisingly we found that some of these "monoclonal" antibodies bound to different varieties of flu virus including "bird" flu. This raises the possibility that these antibodies could be used to treat many varieties of flu in seriously ill patients. The planned research will fill in gaps in basic knowledge of the human immune responses to influenza to shorten the time taken to make life-saving monoclonal antibodies to newly-emerged future viruses. It may also lead to a vaccine that broadly protects against all types of influenza, ending pandemic influenza as a threat.
Program
III: Pandemic Preparedness Strategic Research Initiative
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
198014
Name
Schrader John W
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Immunology & Transplantation
Projecttitle
Characterization of the response of human B lymphocytes to infection with the novel H1N1 pandemic influenza
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
III: Pandemic Preparedness Strategic Research Initiative
Keyworddelim
Human B Cell Reponses; Monoclonal Antibodies; Pandemic H1n1 Influenza; Pandemic Preparedness
Abstract
The H1N1 influenza pandemic arose when a new strain of influenza virus emerged and spread rapidly because most humans had no immunity to it. Immunity to a particular variety of influenza virus is due to the formation of antibodies (proteins that circulate in the blood) that specifically bind to that type of influenza virus and neutralize its ability to infect us. We developed a technique that, this summer, enabled us to generate potentially unlimited amounts of human antibodies that neutralize swine flu. We did this by making faithful copies of antibodies from samples of blood from patients who had recovered from swine flu. Surprisingly we found that some of these "monoclonal" antibodies bound to different varieties of flu virus including "bird" flu. This raises the possibility that these antibodies could be used to treat many varieties of flu in seriously ill patients. The planned research will fill in gaps in basic knowledge of the human immune responses to influenza to shorten the time taken to make life-saving monoclonal antibodies to newly-emerged future viruses. It may also lead to a vaccine that broadly protects against all types of influenza, ending pandemic influenza as a threat.
Competitiondate
200909
Approvedterm2
1 yr 0 mth
Pinamesdelim
Schrader, John W
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~